Clinical Research Directory
Browse clinical research sites, groups, and studies.
Precision Medicine in the Prostate Cancer Care Pathway
Sponsor: Institute of Cancer Research, United Kingdom
Summary
This study aims to evaluate the use of a prostate cancer specific predisposition genetic panel test in men with / at high risk of prostate cancer. The genetic test will analyse men's DNA samples for the presence of mutations in rare genes as well as common genetic variation to provide men with information about their risk of prostate cancer. This study will evaluate the clinical impact of the test on risk assessment and clinical management in terms of screening and treatment.
Official title: Precision Medicine in the Prostate Cancer Care Pathway: an Evaluation of Integrating Germline Genetic Testing Into the Management of Men at Risk of / Living With Prostate Cancer
Key Details
Gender
MALE
Age Range
30 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
3000
Start Date
2019-02-14
Completion Date
2034-12
Last Updated
2025-12-16
Healthy Volunteers
No
Conditions
Interventions
Prostate cancer risk gene panel
A list of genes created by study experts, thought to increase the risk of prostate cancer from from review previous research, this list is regularly reviewed for accuracy
Locations (1)
Royal Marsden Hosital,
Sutton, England, United Kingdom